Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Journal of Molecular and Cellular Cardiology|October 12, 2005
Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary densityAlfred P McQueen, Dongfang Zhang, Ping Hu, et al.
Nature Medicine|August 10, 2000
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intoleranceA Zisman, O D Peroni, E D Abel, et al.
Psychology, Health & Medicine|January 18, 2013
Locus of control, depression and quality of life among persons with sickle cell disease in JamaicaRoger C Gibson, Kai A D Morgan, Wendel D Abel, et al.
Journal of Cardiothoracic and Vascular Anesthesia|September 21, 2010
A prospective, randomized, double-blind trial of 3 regimens for sedation and analgesia after cardiac surgeryWilliam C Oliver, Gregory A Nuttall, Terri Murari, et al.
Annals of Internal Medicine|February 21, 2007
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trialGunjan Y Gandhi, Gregory A Nuttall, Martin D Abel, et al.
The Journal of Clinical Investigation|December 22, 1999
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heartE D Abel, H C Kaulbach, R Tian, et al.
The Science of the Total Environment|June 23, 2023
SARS-CoV-2 wastewater monitoring in rural and small metropolitan communities in Central MichiganMichael J Conway, Stephanie Kado, Breanna K Kooienga, et al.
Respiratory Medicine|December 5, 2024
Sedation during dynamic bronchoscopy for expiratory central airway collapse: Which is the ideal protocol?Rodrigo Funes-Ferrada, Alejandra Yu Lee-Mateus, Bryan F Vaca-Cartagena, et al.
European Urology|December 29, 2015
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal OestradiolRuth E Langley, Howard G Kynaston, Abdulla A Alhasso, et al.
The Lancet. Oncology|March 8, 2013
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.
Pageof 25